Koya Medical (“Koya”), a medical technology company advancing evidence-based therapies for vascular disease, has announced its participation in the J.P. Morgan Healthcare Conference on Wednesday January 14th at 9:00am PST at the Westin St. Francis Hotel in San Francisco. CEO Andy Doraiswamy will highlight the company’s growth and commercial momentum for its portfolio—including Dayspring® non-pneumatic compression treatment for chronic edema—and share progress on the clinical research for its pipeline.
About Koya Medical
Founded in 2018 and headquartered in Dallas, Koya Medical is a medical technology company developing a portfolio of evidence-based treatments designed to improve clinical outcomes and patient experience in vascular disease.
Why Vascular Health Matters
More than 35 million Americans live with venous and lymphatic diseases—serious yet often overlooked conditions that can severely impact mobility, quality of life, and long-term health—highlighting the urgent need for modern, evidence-based, and scalable solutions.
